Marek Honczarenko

Insider Reports History

Location
Hazelwood, MO
Signature
/s/ Mark Tyndall, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marek Honczarenko:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keenova Therapeutics plc EVP, Chief Scientific Officer Restricted Stock Units 58,434 25 Feb 2026 Direct

Insider Reports Filed by Marek Honczarenko

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465926020874-honczarenko-marek-2026-02-25 Keenova Therapeutics plc 25 Feb 2026 1 $0 4 EVP, Chief Scientific Officer 26 Feb 2026, 21:13
/report/000110465925095750-honczarenko-marek-2025-09-29 Mallinckrodt plc 29 Sep 2025 0 $0 3 EVP & Chief Scientific Officer 01 Oct 2025, 19:28